Supplementary Figure 1 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs

We only have this paper's title and publication details.

Supplementary results demonstrate superior efficacy in HER2 targeting drug conjugates, suggesting benefits over IgG-based options.